MDWD: MediWound Ltd. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 176.06
Enterprise Value ($M) 166.90
Book Value ($M) 31.15
Book Value / Share 2.88
Price / Book 5.65
NCAV ($M) 9.82
NCAV / Share 0.91
Price / NCAV 17.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.79
Return on Assets (ROA) -0.48
Return on Equity (ROE) -1.30

Liquidity (mrq)
Quick Ratio 1.86
Current Ratio 1.97

Balance Sheet (mrq) ($M)
Current Assets 52.16
Assets 73.50
Liabilities 42.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 20.22
Operating Income -19.40
Net Income -30.22

Cash Flow Statement (mra) ($M)
Cash From Operations -13.62
Cash from Investing -8.40
Cash from Financing 19.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Point72 Asset Management, L.P. 0.10 -98.57
10-23 13G/A Rosalind Advisors, Inc. 5.80 22.31
10-01 13G Yelin Lapidot Holdings Management Ltd. 6.96 96.55
07-19 13D/A Access Industries Holdings LLC 13.80
07-19 13D Molnlycke Health Care AB 8.10

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 31,306 132,256 23.67
2025-04-16 2,746 16,615 16.53
2025-04-15 5,474 21,638 25.30
2025-04-14 12,488 40,407 30.91

(click for more detail)

Similar Companies
LNTH – Lantheus Holdings, Inc. LRMR – Larimar Therapeutics, Inc.
LXEO – Lexeo Therapeutics, Inc. MIRM – Mirum Pharmaceuticals, Inc.
MNKD – MannKind Corporation


Financial data and stock pages provided by
Fintel.io